Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults

Detaylı Bibliyografya
Asıl Yazarlar:	Harris, S, Meyer, J, Satti, I, Kostov, M, Rowland, R, Poulton, I, Poyntz, H, Tanner, R, Lillie, P, Lawrie, A, Hill, A, Mcshane, H
Materyal Türü:	Conference item
Baskı/Yayın Bilgisi:	2011

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
Yazar:: Meyer, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
Yazar:: Meyer, J, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
Yazar:: Rowland, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
Yazar:: Harris, S, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Yazar:: Pathan, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
Yazar:: Pathan, A, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
Yazar:: Whelan, K, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
Yazar:: Mcshane, H
Baskı/Yayın Bilgisi: (2008)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
Yazar:: Rowland, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
Yazar:: Harris, SA, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
Yazar:: Kathryn T. Whelan, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Evaluating aerosol administration of a candidate TB vaccine MVA85A
Yazar:: Thomas, Z, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults.
Yazar:: Minhinnick, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.
Yazar:: Scriba, T, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control
Yazar:: Wajja, A, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial
Yazar:: Wajja, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
Yazar:: Mcshane, H, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
Baskı/Yayın Bilgisi: (2011-01-01)

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial.
Yazar:: Anne Wajja, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
Yazar:: Minassian, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trial.
Yazar:: Satti, I, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: A phase 1, double-blind, randomised controlled trial
Yazar:: Satti, I, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
Yazar:: Fletcher, H, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
Yazar:: Owiafe, P, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
Yazar:: de Cassan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
Yazar:: Griffiths, K, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

CD4 T cell response to MVA85A vaccination against Mycobacterium tuberculosis in healthy HIV-infected adults
Yazar:: Beveridge, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A (vol 17, pg 1066, 2010)
Yazar:: de Cassan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A (Clinical and Vaccine Immunology (2010) 17, 7, (1066-1073))
Yazar:: De Cassan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
Yazar:: Mcshane, H, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

MVA85A: characterising the innate immune responses after vaccination and the effect of TLR1 levels on the acquired antigen-specific immune response
Yazar:: Kostov, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

A Phase I, Open-Label Trial, Evaluating the Safety and Immunogenicity of Candidate Tuberculosis Vaccines AERAS-402 and MVA85A, Administered by Prime-Boost Regime in BCG-Vaccinated Healthy Adults
Yazar:: Sheehan, S, ve diğerleri
Baskı/Yayın Bilgisi: (2015)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Yazar:: Tameris, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
Yazar:: Sander, C, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
Yazar:: Tameris, M, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
Yazar:: Minassian, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
Yazar:: Tameris, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Phase I trial evaluating the safety and immunogenicity of candidate TB vaccine MVA85A, delivered by aerosol to healthy M.tb-infected adults
Yazar:: Riste, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial
Yazar:: Tameris, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Yazar:: Michele Tameris, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults

Benzer Materyaller

Benzer Materyaller